Rolf Barth

Rolf Barth is a Professor in the Department of Surgery-Transplant at the University of Chicago. He serves as Director of Liver Transplantation and Associate Director of The University of Chicago Medicine Transplant Institute. His clinical expertise includes kidney, pancreas, and liver transplantation, with a focus on living donor procedures and minimally invasive surgery, having performed over 500 single-port laparoscopic donor nephrectomies.

• Education:
  • Duke University, MD (1997)
  • Mass. General Hosp/Harvard Medical School, Transplant Immunology Fellowship (2001)
  • Duke University, General Surgery Residency (2004)
  • University of Wisconsin, Transplant Surgery Fellowship (2006)

Dr. Barth's research spans novel immunosuppressive therapies, transplant tolerance, and genetically engineered xenotransplantation. His lab investigates pre-clinical models for facial and limb transplantation toward reconstructive goals. Recent publications focus on liver and kidney transplant outcomes, immunosuppression protocols, and machine perfusion, with keywords like Transplantation, General Surgery, and Virology.

Clinical grants include studies on normothermic machine perfusion, islet transplantation, and COVID-19 in transplant recipients. Collaborators include John LaMattina, Piotr Witkowski, and Arielle Cimeno. He has contributed to over 400 citations in PubMed, with a focus on transplant immunology and regenerative medicine.